UnitedHealth Group has recently been in the spotlight due to several controversies and strategic shifts. The company faced allegations, reported by The Guardian, of secretly paying nursing homes to reduce hospital transfers, a claim UnitedHealth denied, citing a U.S. Department of Justice finding that the charges were inaccurate. Nevertheless, the report negatively impacted UnitedHealth's stock price, which is currently at $295.57, reflecting a slight decrease from previous levels.
In a sudden change of leadership, CEO Andrew Witty has stepped down, citing personal reasons, during a period of rising medical costs and declining share value. Stephen Hemsley, who formerly led the company from 2006 to 2017, has returned as CEO. He has been granted a $1 million annual salary and a $60 million equity award as part of his compensation package. Additionally, UnitedHealth has increased its security expenditures significantly, spending nearly $1.7 million in 2024 following the tragic shooting of former CEO Brian Thompson.
Legal challenges add to UnitedHealth's current landscape, including a lawsuit from investors over withheld information following Thompson's death and an ongoing Department of Justice fraud investigation into UnitedHealth's Medicare Advantage billing practices. Additionally, the company revised its 2025 financial outlook, expecting adjusted earnings of $26 to $26.50 per share due to unexpected rises in medical care usage. These developments reflect the heightened scrutiny and instability the healthcare giant is facing.